XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.60−0.04 (-2.44%)
Close on Nov 13, 2026Market cap $15.14MP/E –Yield –
XTL Biopharmaceuticals cash
Cash and short-term investments held at the end of each period.
XTL Biopharmaceuticals's cash was $76.00K at Dec 31, 2025. For fiscal 2025 it was $76.00K, down 79.5% from the year before. Over ten years it grew -32.4% a year on average. The highest annual figure on record is $6.73M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.00K | -79.5% |
| FY2024 | Dec 31, 2024 | $371.00K | -73.5% |
| FY2023 | Dec 31, 2023 | $1.40M | -33.1% |
| FY2022 | Dec 31, 2022 | $2.09M | -29.5% |
| FY2021 | Dec 31, 2021 | $2.97M | -50.9% |
| FY2020 | Dec 31, 2020 | $6.04M | -10.2% |
| FY2019 | Dec 31, 2019 | $6.73M | +106.7% |
| FY2018 | Dec 31, 2018 | $3.26M | -1.0% |
| FY2017 | Dec 31, 2017 | $3.29M | +62.9% |
| FY2016 | Dec 31, 2016 | $2.02M | -47.1% |
| FY2015 | Dec 31, 2015 | $3.82M | +76.8% |
| FY2014 | Dec 31, 2014 | $2.16M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $76.00K | -96.8% |
| Q4 FY2024 | Dec 31, 2024 | $371.00K | -87.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.40M | -77.8% |
| Q4 FY2022 | Dec 31, 2022 | $2.09M | -65.3% |
| Q2 FY2022 | Jun 30, 2022 | $2.35M | -41.7% |
| Q4 FY2021 | Dec 31, 2021 | $2.97M | -55.9% |
| Q2 FY2021 | Jun 30, 2021 | $6.30M | +93.5% |
| Q4 FY2020 | Dec 31, 2020 | $6.04M | +83.7% |
| Q2 FY2020 | Jun 30, 2020 | $4.03M | +99.5% |
| Q4 FY2019 | Dec 31, 2019 | $6.73M | +76.3% |
| Q4 FY2018 | Dec 31, 2018 | $3.26M | +50.8% |
| Q4 FY2017 | Dec 31, 2017 | $3.29M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.02M | – |
| Q4 FY2015 | Dec 31, 2015 | $3.82M | – |
| Q4 FY2014 | Dec 31, 2014 | $2.16M | – |
See a number that looks wrong?